Skip to main content

Animations

MJFF Publications

2631 - 2640 of 6617 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab374
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awac281
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A Severe Case of Lupus Cerebritis
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903100.95793.8a
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 Sequences
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903160.72715.2d
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete Recovery
    Journal Name: Annals of Otology, Rhinology & Laryngology
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/00034894221138485
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Non-reference genome transposable elements (TEs) have a significant impact on the progression of the Parkinson’s disease
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/15353702221117147
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolites
    Journal Name: Journal of Cerebral Blood Flow & Metabolism
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/0271678x221126830
    Citation Count: 11
  • Summary Details
    OPEN
    Title: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer's Disease and Related Research
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.14283/jpad.2022.7
    Citation Count: 1
  • ECTRIMS 2022 – Poster
    2022
    Summary Details
    OPEN
    Title: ECTRIMS 2022 – Poster
    Journal Name: Multiple Sclerosis Journal
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/13524585221123687
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Longitudinal tracking of neuronal mitochondria delineates PINK1/Parkin-dependent mechanisms of mitochondrial recycling and degradation
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.abf6580
    Citation Count: 44
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.